Please login to the form below

Not currently logged in

Inovio Biomedical elects new Board members

Inovio Biomedical Corporation has announced the election of David J Williams and Keith H Wells to its Board

DNA vaccine design, development and delivery firm Inovio Biomedical Corporation has announced the election of David J Williams, former chairman and CEO of Sanofi Pasteur, and Keith H Wells, a senior member of the Biologics Consulting Group and former director of vaccine development for The Salk Institute, to its Board. 

Dr J Joseph Kim, president and CEO of Inovio, said: "These two business leaders each have multiple decades of experience leading and executing the development and commercialisation of cutting-edge vaccine technology and important new vaccines. Their expertise will be invaluable to Inovio as we advance a new generation of vaccines – DNA vaccines delivered using the potency-enhancing capabilities of electroporation – that are displaying superior results and potential to not only prevent but treat challenging infectious diseases and cancers."

26th October 2009


Featured jobs

Subscribe to our email news alerts


Add my company

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...